Stock GLYC GLYCOMIMETICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus GlycoMimetics, Inc.

Equities

GLYC

US38000Q1022

Real-time Estimate Cboe BZX
Other stock markets
 03:35:19 2024-04-29 pm EDT 		5-day change 1st Jan Change
1.585 USD -3.35% Intraday chart for GlycoMimetics, Inc. -12.22% -33.05%
Mar. 27 Transcript : GlycoMimetics, Inc., Q4 2023 Earnings Call, Mar 27, 2024
Mar. 27 GlycoMimetics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Evolution of the average Target Price on GlycoMimetics, Inc.

Price target over the last 5 years

History of analyst recommendation changes

e44dcc03e885b99d0d62e0b0.936zIsnUkeXUhEVa9HJiUkXMIZd4b1jIDuaJP8Yo3mo.mAnkFLij0rCD4jFvgTwTETeDEMdVFT-GZdTlVrJ5rDjPJ9RWuY6o0pjeJg~b5101b2279b3d68a3bf4303fe7c2f7bc

Analyst Recommendations on GlycoMimetics, Inc.

Capital One Initiates GlycoMimetics With Overweight Rating, Price Target is $12 MT
HC Wainwright Adjusts GlycoMimetics Price Target to $13 From $14, Maintains Buy Rating MT
Jefferies Raises GlycoMimetics to Buy From Hold, Price Target to $4 From $3 MT
GLYCOMIMETICS : Roth Capital Adjusts GlycoMimetics' Price Target to $15 From $9, Reiterates Buy Rating MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
1.64 USD
Average target price
7 USD
Spread / Average Target
+326.83%
High Price Target
10 USD
Spread / Highest target
+509.76%
Low Price Target
3 USD
Spread / Lowest Target
+82.93%

Consensus detail

Consensus revision (last 18 months)

Analysts covering GlycoMimetics, Inc.

Capital One Securities
HC Wainwright
Jefferies & Co.

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. GLYC Stock
  4. Consensus GlycoMimetics, Inc.